Real-World Cost Effectiveness of a Policy of KRAS Testing to Inform Cetuximab or Panitumumab for Third-Line Therapy of Metastatic Colorectal Cancer in British Columbia, Canada
Article in PharmacoEconomics - Open (October 2023)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
Article in PharmacoEconomics - Open (October 2023)
Article in PharmacoEconomics (July 2022)
Article in Cancer Medicine (July 2022)